Report Description:

Global Data, the industry analysis specialist, has released its latest report, Country Focus: Healthcare, Regulatory and Reimbursement Landscape Singapore. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Singapore. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

For More Information:

Singapores population grew from 4.8 million in 2008 to 5.4 million in 2013, mainly due to the increase in the life expectancy (DoS, 2014). The value of the pharmaceuticals market increased from $489m in 2008 to $761m in 2013 at a Compound Annual Growth Rate (CAGR) of 9.3%, and this value is expected to increase further from $776m in 2014 to $873m in 2020 at a CAGR of 2.0% (Tarn et al., 2008; DoS, 2014; EDB, 2014c). In 2011, the output of the medical technology sector was SGD4.3 billion ($3.4 billion), which is expected to increase to SGD5 billion ($4 billion) in 2015 (EDB, 2014a).

These positive growth trends can primarily be attributed to

  • Government initiatives
  • Universal healthcare coverage


The report provides information on the healthcare, regulatory, and reimbursement landscape in Singapore, and includes –

Overview of the pharmaceutical market including size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Haw Par Corporation, SciGen, Pfizer, Novartis and GlaxoSmithKline

Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the countrys healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the Singaporean healthcare market

Browse All Reports Of This Category:

Reasons to buy:

  • This report will enhance your decision-making capability by allowing you to –
  • Develop business strategies by understanding the trends shaping and driving Singapores healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Singapores healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in Singapores healthcare market

1 Table of Contents 6

1.1 List of Tables 10

1.2 List of Figures 14

2 Introduction 18

2.1 Global Data Report Guidance 18

3 Overview of Pharmaceutical and Medical Device Market 19

3.1 Pharmaceutical Market 19

3.1.1 Market Overview 19

3.1.2 Pharmaceutical Exports and Imports 24

3.1.3 Supply Channels 25

3.1.4 Market Segments 26

3.1.5 Overview of Major Disease Areas 29

3.1.6 Major Players 31

3.2 Medical Device Market 64

3.2.1 Market Overview 64

3.3 Market Drivers and Barriers 65

3.3.1 Drivers 65

3.3.2 Barriers 66

Click Here To Download Detail Report:

4 Market Access 68

4.1 Reimbursement and Payer Landscape 68

4.1.1 Overview of Healthcare System 68

4.1.2 Reimbursement Process 71

4.1.3 Overview of Insurance Providers 72

4.1.4 Patient Share in Healthcare Spending 76

4.1.5 Price Trends in the Healthcare Sector 78

4.1.6 Pricing Policies 79

4.2 Regulatory Landscape 79

4.2.1 Overview of Regulatory Agencies 79

4.2.2 Market Authorization Procedure for Pharmaceutical Products 84

4.2.3 New Medical Device Approval Process 89

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 92

4.2.5 Exports and Imports 94

4.2.6 Intellectual Property Rights 96

4.2.7 Clinical Trial Regulations 112

4.2.8 Pharmaceutical Advertising Regulations 118

4.2.9 Pharmacy Regulations 119

4.2.10 Labeling and Packaging Regulations 121

All Reports Of This Publisher:

About Acute Market Reports:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.  We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Contact Us:
Chris Paul
Sales Manager
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Web: AcuteMarketReports